Sitemap
February 09, 2019 Articles
Filter by Available Specialty
- Dalbavancin works as secondary therapy for S. aureus in patients who use drugs
- Diabeloop introduces artificial pancreas technology adapted for children
- GEM: Family history, microbiome, permeability can stratify high-risk IBD
- Harvard professor to receive cancer drug development award
- Modest daily drinking increases risk for ischemic stroke
- Significant barriers remain for patients accessing IBD care
- Stryker releases fourth-quarter, year-end 2018 results and 2019 outlook
- VIDEO: Consider resistance severity in glaucoma treatment decisions
- VIDEO: Diet, nutrition may offer ‘precision medicine’ approach to IBD
- VIDEO: Social networking crucial to ‘cultivate the next generation’